BEKAY yields 4.69% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, BEKAY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BEKAY + JNJ for your $10,000?
NV Bekaert SA provides steel wire transformation and coating technologies worldwide. The company operates through four business units: Rubber Reinforcement, Steel Wire Solutions, Specialty Businesses, and Bridon-Bekaert Ropes Group. It offers tire cord and bead wire products for tire sector; hose reinforcement wire and conveyor belt reinforcement products; and steel wire products and solutions for agriculture, energy and utilities, mining, construction, consumer goods, and the industrial sectors. The company also provides ropes for a range of sectors, including surface and underground mining, offshore and onshore energy, crane and industrial, fishing and marine, and structures; fine steel cords for elevator and timing belts; and window regulator and heating cords for the automotive sector. In addition, it offers building products that reinforce concrete, masonry, plaster, and asphalt; fiber technologies for the filtration, heat-resistant textiles, electroconductive textiles, hydrogen electrolysis technologies, the safe discharge of static energy, sensor technologies, and the semiconductor business; and combustion technologies for gas and hydrogen burners, and residential and commercial heat exchangers. The company was founded in 1880 and is headquartered in Zwevegem, Belgium.
Full BEKAY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.